Briefing Material

for the year ended Dec. 31, 2021

Feb. 18, 2022
NAKANISHI INC.

Disclaimer
The information presented in these materials contains forward-looking statements about futurebusiness performance. These statements by definition involve risks and uncertainties and are
not intended to guarantee future performance. Actual results in the future may differ fromexpectations and the projections presented in these materials due to changes in the global
economy and fluctuations in foreign currency exchange rates and so on. NSKNSKNSKNSKNSK© 2022 NAKANISHI INC.

Contents

Consolidated Financial Results for FY2021

3

Consolidated Financial Forecast for FY2022

11

Overviews of Each Segment and Future Initiatives 15© 2022 NAKANISHI INC.

2

FY2021
Consolidated Financial Results© 2022 NAKANISHI INC.

3

FY2021 Consolidated P/L
FY2021
Forecast

FY2021
ActualFY2020
ActualNet Sales

44,85733,055+35.7 %

41,661+7.7 %

Gross Profits

27,295

19,731+38.3 %

25,597+6.6 %

60.8 %

59.7 %+1.2 pt

61.4 %-0.6 pt

13,7508,542+61.0 %

13,001+5.8 %

30.7 %

25.8 %+4.8 pt31.2 %-0.6 pt

13,951

8,627+61.7 %

12,988+7.4 %

Ratio to net sales

31.1 %

26.1 %+5.0 pt31.2 %-0.1 pt

Profit attributable to ownersof parents

10,102

6,455+56.5 %

9,338

+8.2 %

Ratio to net sales

22.5 %

19.5 %+3.0 pt

22.4 %+0.1 pt(JPY)

116.73

74.49

Against the US dollar(JPY)

109.84106.67+3.17 (weaker JPY)

105.00+4.84 (weaker JPY)

Against the EURO(JPY)

130.08122.01+8.07 (weaker JPY)

125.00+5.08 (weaker JPY)

M of JPY

Ratio to net sales

Operating Income
Ratio to net sales

Ordinary Income

E

P

S

YoY ComparisonーUpward revisionon Aug. 6

108.52

Ratio to the
ForecastーCurrency rate

▪ Forex impact:

Net sales +1,557M of JPY (vs FY2020 Actual), +2,522M of JPY (vs FY2021 Forecast)▪ Forex sensitivity: Fluctuation in annual net sales due to the depreciation of the yen (per one yen)
Against USD: Increase of 84M of JPY
Against EURO: Increase of 79M of JPY© 2022 NAKANISHI INC.

4

Change in Net Sales by Business Segment
M of JPY

31,00044,857+220+1,557

OthersIndustrial +17.1%+32.7%

Forex
impact+896

26,00033,055

FY2021
ActualChange29,025

38,152+9,127

Industrial

2,740

3,637

+896

Others

1,289

1,510

+220

-

+1,557+1,55733,05544,857+11,802

Forex impact

Dental+31.4%

16,000

FY2020
ActualDental+9,12721,000▶ Net sales by business segment

Total

Based on forex as of FY2020
11,000

FY2020Net sales

FY2021
Net sales© 2022 NAKANISHI INC.

5

Dental Segment

Change in Net Sales by Region

M of JPY
28,00026,00039,64524,000▶ Net sales of Dental segment by region
FY2020
ActualFY2021
ActualChangeEurope9,519

12,415+2,896

Japan

6,735

7,426

+690

North
America

4,183

6,950

+2,766

Asia

4,147

5,578

+1,431Others

4,440

5,781

+1,341Forex
impact-+1,492+1,492

29,02539,645+10,619+1,49222,000+1,341 Forex+1,431 Others

20,000Asia+30.2%+2,766 +34.5%

18,000+690 N. America

16,000Japan+2,896 +10.2%

29,02514,00012,000impact+66.1%

Europe+30.4%

10,000

Based on forex as of FY2020

Total

8,000

FY2020DentalNet sales

FY2021
DentalNet sales© 2022 NAKANISHI INC.

6

Industrial Segment

Change in Net Sales by Region

M of JPY
2,700

2,500

+0

3,664

+27

▶ Net sales of Industrial segment by region

2,300

+ 119
2,100

+180

Europe+30.8%

N. America

1,900

+396

+25.7%

1,700

1,500

1,300

2,740

+199

FY2020
ActualFY2021
ActualChange

Japan

958

1,158

+199

Asia

684

1,080

+396

North
America

704

885

+180

Europe

387

506

+119

Others

6

6

+0

Forex
impact

-

+27

+27

2,740

3,664

+923

Others Forex
impactAsia+57.9%

Japan+20.9%

1,100

Based on forex as of FY2020

Total
900

FY2020Industrial
Net sales

FY2021
Industrial
Net sales© 2022 NAKANISHI INC.

7

Change in Operating Income
M of JPY

Exchange rate
FY2020 average FY2021 average

USD: 106.67JPY → 109.84JPY
EURO: 122.01JPY → 130.08JPY
15,000-109
Product
mix

13,000+ 6,115

11,0009,000

13,750-760
Increasein selling
expenses-1,213- 28

Increase
Increasein personal in otherexpenses expenses+1,204Forex
impact8,542
Increasein demand

7,000

Based on forex as of FY2020
5,000

FY2020OP income

FY2021
OP income© 2022 NAKANISHI INC.

8

Consolidated Balance Sheet
As of
Dec. 31, 2021

As ofDec. 31, 2020

Change94,46082,470+11,990

5,348

5,158

+190

- Inventories

11,733

10,604+1,129- Merchandise and finished goods +1,335- Work in process-219- Raw materials and supplies+13

Liabilities

11,541

6,198+5,342- Accounts payable- Other current liabilities

100

100

ー

Net assets

82,91976,272+6,647- Retained earnings

84,76577,435+7,329Return on equity (ROE)

12.7 %

8.7 %+4.0 pt

Return on assets (ROA)

15.8 %

10.8 %+5.0 pt

As ofDec. 31, 2021

As ofDec. 31, 2020

ChangeCapital Investments

2,415

1,163

+1,252

Depreciation expenses

1,807

1,759

+48

M of JPY

Total assets- Notes and accounts
receivable-trade- Loans payable© 2022 NAKANISHI INC.

Note
- Cash and deposits+3,746+202+3,587Note

9

FY2021 Net Sales Figure by Segment and Region (Including Forex Impact）
M of JPY

DentalJapan

Export
sub total

EuropeNorth
America

Asia

OthersTotal

FY2020 Actual

6,735

22,289

9,519

4,183

4,147

4,440

29,025

FY2021 Actual

7,426

32,21913,234

7,139

5,933

5,911

39,645

Amount+690+9,929+3,715+2,956+1,786+1,471+10,619+10.2 ％

+44.5 ％

+39.0 ％

+70.7 ％

+43.1 ％

+33.1 ％

+36.6 ％FY2020 Actual

958

1,782

387

704

684

6

2,740

FY2021 Actual

1,158

2,506

506

911

1,081

6

3,664

Amount

+199

+723

+119

+207

+396

+0

+923

Ratio

+20.9 ％

+40.6 ％

+30.8 ％

+29.4 ％

+58.0 ％

+6.7 ％+33.7 ％FY2020 Actual

791

497

155

202

124

16

1,289

FY2021 Actual

855

693

269

232

166

25

1,548

Amount

+63

+195

+114

+30

+41

+9

+258

+8.0 ％+39.3 ％

+73.5 ％

+15.1 ％

+33.7 ％

+56.1 ％

+20.1 ％FY2020 Actual

8,485

24,56910,061

5,090

4,955

4,462

33,055

FY2021 Actual

9,439

35,41814,010

8,284

7,180

5,943

44,857

Amount+953+10,848+3,948+3,193+2,224+1,480+11,802+11.2 ％

+44.2 ％

+39.2 ％

+62.7 ％

+44.9 ％

+33.2 ％

+35.7 ％

YoY

Industrial

YoY

Others

YoY

Total

YoY

Ratio

Ratio

Ratio

© 2022 NAKANISHI INC.

10

Consolidated Financial Forecast
for FY2022© 2022 NAKANISHI INC.

11

Consolidated Financial Forecast for FY2022
M of JPY

FY2022
Forecast

FY2021
ActualChangeNet Sales

41,24444,857-8.1 %

Gross Profits

25,58527,295-6.3 %

62.0 %

60.8 %+1.2 pt

10,67813,750-22.3 %

25.9 %

30.7 %-4.8 pt

11,122

13,951-20.3 %

27.0 %

31.1 %-4.1 pt

Profit attributable toowners of parents

7,824

10,102-22.5 %

Ratio to net sales

19.0 %

22.5 %-3.6 pt

E

(JPY)

90.81

116.73ーCapital Investments

4,016

2,415

+1,600Depreciation
Expenses

2,036

1,807

+228

Against the US dollar (JPY)

109.00109.84-0.84 (stronger JPY)

Forex sensitivity: Annual net sales canfluctuate 94M of JPY per one JPY.

Against the EURO123.00130.08-7.08 (stronger JPY)

Forex sensitivity: Annual net sales canfluctuate 69M of JPY per one JPY.

Ratio to net sales

Operating Income
Ratio to net sales

Ordinary Income
Ratio to net sales

P

S

Note

FY2022: New plant A1+: 1,988

Assumed Currency rate

(JPY)

© 2022 NAKANISHI INC.

12

Assumptions for Consolidated Financial Forecast for FY2022
First half
[Net sales]

Full year

25,00023,014
19,749[Cost of sales]

20,0009,099

50,00044,857[Net sales]

15,00041,24445,000[Selling, general and
10,000administrative expenses]

6,267

7,492

7,467

YoY

-3,264（-14%）
Lower production
due to challenges
in components
procurement

40,0005,000[Cost of sales]
35,000[Operating income]

17,562
15,65830,00013,5440

For FY2022 H2, net sales are expected
to recover to the same level as FY2021
H2 as these challenges are clearedaway.

25,000[Selling, general and
20,000administrative expenses]

Net sales for FY2022 H1 are expected
to be lower due to challenges incomponents procurement.

14,9077,646
FY2021 H1Actual4,789
FY2022 H1Forecast

YoY-2,856（-37%）

Second half

21,843[Net sales]

21,49415,000

YoY

-349

（-2%）

20,000[Cost of sales]

10,00013,750[Operating income]
5,000

8,462

8,166

7,277

7,439

6,103

5,888

15,00010,678[Selling, general 10,000
andadministrative expenses]

Sales expected torecover, withproduction backto normal0

FY2021
ActualFY2022
Forecast

5,000[Operating income]0© 2022 NAKANISHI INC.

FY2021 H2ActualFY2022 H2Forecast

YoY

-214

（-4%）

13

Shareholder Return Policy and Transition
Shareholder return policy
We position the return of profits to our shareholders as one of the important management issues; therefore,
we plan to enhance business foundation and promote investment in growth areas properly and proactively, as
well as to return profits to shareholders in a well-balanced manner.
We endeavor to perform flexible acquisition of treasury stock and stable and continuous dividend increase
with considering retained earnings required for future growth investment, and setting the standard for
medium-term profit return as a total return ratio of 50%.

100.0

* Calculated with the 5-for-1 stock split in Apr. 2014
and the 3-for-1 stock split in Apr. 2018 consideredTransition of shareholder return

90.0
■

80.0
■

Total annual dividend (100M of JPY)

60.0

35.1%

50.0

40.3%
36.8%
32.7%

35.4%

36.6%

40 .0%

Treasury stockacquisition

30.7%

10.0
0.0

(maximum as of today)

11.9
11.9
22.4%

9.8

50 .0%

43.5%

40.0

20.0

60 .0%

50%

Total amount of treasury stock acquisition (100M of JPY)

70.0 Total payout ratio

30.0

Total payout ratio
Medium-term standards

9.8

1.1

3.5
7.0

14.5

13.0

17.3

2013

2014

2015

2016

1.2

0.0

500M of JPY
30 .0%

0.0

Total annual dividend
20 .0%

22.5

26.8

25.9

25.9

2017

2018

2019

2020

(forecast announced
on Feb.9)

31.9

3.46B of JPY
10 .0%© 2022 NAKANISHI INC.

2021

2022
Forecast

14

Overviews of Each Segment
and Future Initiatives© 2022 NAKANISHI INC.

15

History of Consolidated Net Sales
FY2021 closed with second-half net sales
exceeding the strong FY2020 H2 results
6,000

5,000

Q1

Q2

Q3

Q4

11.33B of JPY

11.67B of JPY

10.45B of JPY

11.38B of JPY

YoY

YoY

YoY

YoY

＋4.04B of JPY＋5.28B of JPY＋1.86B of JPY＋0.61B of JPY

4,000

FY20213,000
FY2020FY2019
2,000

1,000

Jan

Feb

Mar

Apr

May

Jun

Jul

© 2022 NAKANISHI INC.

Aug

Sep

Oct

Nov

Dec
16

Global Trend of Net Sales
H1: Sales increased across all regions, with significant growth in Japan,
Europe and North America in particular.
H2: Sales decreased in Japan due to the termination of subsidies, while
overseas sales remained strong in Europe, North America, etc.

YoY change in net sales by region
Unit : 100M of JPY

EuropeN. America

H1: +24.5
H2: +14.9

H1: +19.0
H2: +12.8

Japan
H1: +24.0
H2: -14.5

Asia
H1: +13.6
H2: +8.5

South America, Russia,
Middle East, Australia, etc.

OthersH1: +11.8
H2: +2.9© 2022 NAKANISHI INC.

17

Mid term Management Plan “NV2025” - Progress in FY2021
Mid term Management Plan “NV2025” (6 year plan for FY2020 to FY2025) is being
carried out in order to realize our long-term vision“To be The Leading Excellent Global Medical Device Company”

Mid term Management Plan “NV 2025”

Progress in FY2021

Basic policy and priority measures
1. Strategic expansion in Dental
global market
2. Growing new business forcustomer needs in super
population ageing
3. Establish infrastructure for speedy
product development and leading
cost competitivenessProfit objectives for FY2025
Net sales: 50B of JPY
Operating Profit Ratio: 28%

1. Renewed record-high results andachieved an increase in global market
share
2. Achieved significant sales growth in
the Chinese market
3. Achieved significant sales growth andan increase in share in the U.S. market
4. Began construction of the new plant
A1+ for production capacity expansion
5. Accelerating sustainability
management
The base line of global sales rose due toexpansion of global market share amid the
COVID-19 pandemic.
Worked to enhance production capacity andcontinued measures to address on-goingsupply chain disruptions© 2022 NAKANISHI INC.

18

Mid term Management Plan “NV2025”- Topline Trends

FY2022 topline forecast is in line with the net sales target of
60,00050Bof JPY under the Mid term Management Plan “NV2025.”

NV2025net sales
target55,00050,00050,000

FY2022net sales
forecast

44,85745,00041,244

M of JP

40,00036,54335,00034,341
31,86235,41831,829⊕ Record-high backlog of

30,000⊖25,00020,000

Factors of change
in short-term
performance

33,055

⊖

2015

2016

2017

2018

2019

2020

2021

© 2022 NAKANISHI INC.

ordersDecrease in productionof some products due tochallenges incomponents
procurement
Decline due to a reversalof extraordinary demandin Japan2022

Factors of change
in medium-term
performance⊕ Growth of the dental⊕⊕

market and an increase inglobal market share
Expansion of operationsin priority markets (U.S.
and China)
Expansion of production
capacity by bringing newplant A1+ into operation

2025
19

Basic strategy for FY2022

Forecast of market trends in FY2022- Demand -- Supply -Increase in demand backed by
global implementation of
infection prevention measures

Continued challenges inprocuring semiconductors,
electronic components, etc.

Basic strategy for FY2022
Consolidate our position as the world’s leading brandby enhancing the lineup of handpieces, implant related products
and oral hygiene products, while also enhancing
our sales capabilities and brand power© 2022 NAKANISHI INC.

20

Dental Business Market Status 1/3

Overview of FY2021

Measures for FY2022▪ Strong demand for handpieces

continued, as new sterilization
protocols, adopted since
the COVID-19 outbreak, require
more use of handpieces.

Net sales

Europe13.23B JPY▪

Share of our own brand in Europe
showed strong growth. We
won contracts with dental
colleges, an area that had
been dominated by competitors.

▪

OEM Business grew significantly.

▪

As extraordinary demand peakedout with the termination of
government subsidies, sales for H2
declined as expected, but full-year
results turned out to be about thesame as FY2020.

YoY+39.0%Net salesJapan

7.42B JPY
YoY

+10.2%▪

Sales in OEM Business showedsignificant growth, largely
contributing to increased sales inJapan.

© 2022 NAKANISHI INC.

Marketoutlook▪ Expand the sales of handpieces
for dental treatment and“Surgic Pro2,” a device for
implant treatment.
▪ Develop and strengthen
NSK Dental Nordic,
a new Nordic sales center.

Marketoutlook▪ Sales are expected to decline
significantly due to the reverseof the extraordinary demand in
FY2021.
▪ Continue the measures
to promote sales expansion ofhandpieces, our main productline, as well as preventive
dentistry products and“Surgic Pro2,” a new device for
implant treatment.

21Dental Business Market Status 2/3
Overview of FY2021

Net sales
North
America

7.13B JPY
YoY▪

Sales of both our own brand andOEM businesses were strong.

▪

Sales increased significantly as
we captured demand of shifting toelectric motors.

+70.7%

Measures for FY2022

Marketoutlook▪ The shift to electric motors is
expected to continue.
Capture demand related toelectric motors, an area where
NAKANISHI has strengths,
to a maximum extent.
▪ Strengthen sales promotion todental colleges and DSOs*,a segment that we have yet
to tap.

＊ DSOs: Dental Service Organizations

Net sales▪

5.93B JPY
Asia▪

Sales in South Korea also largely
increased as sales to South Korea
and OEM supply were both strong.

▪

Sales to Southeast Asian countries
were sluggish.

YoY+43.1%

Sales in China grew significantly as
the enhancement of our Chinese
subsidiary and the buildup of our
local sales agency network
progressed.

© 2022 NAKANISHI INC.

Marketoutlook▪ Continue the strengthening of thesales system and the enhancementof sale agency network. Closely
watch the direction of the measuresby the Chinese government tosupport products made in China.
▪ After the significant growth in
FY2021, sales in the South Koreanmarket are expected to largely
decline as the strong demand peaks
out and reverses.
▪ The Southeast Asian market, hard
hit by the pandemic, is expected
to recover.

22

Dental Business Market Status 3/3

Overview of FY2021
MiddleEast▪ Sales improved as we captured
the pent-up demand resulting fromcautious purchasing behaviors
found earlier in the pandemic.

South
Net sales
America▪ With our market presence further
increased due to competitors’
withdrawal from the market, sales
increased significantly.

5.91B JPY
YoY

RussiaAustralia+33.1%▪ Sales increased as demand remainedsolid despite the COVID-19 pandemic.

▪Sales grew benefitting from the
tailwinds of government measuresproviding preferential tax breaks.

© 2022 NAKANISHI INC.

Measures for FY2022
MarketoutlookMarketoutlook▪Strengthen efforts to win
contracts with governments,
colleges and large-scaledental clinics, a segment
where demand is recovering.

▪ Expand the sales of handpieces,
our main product line, andimplant related products.

Marketoutlook▪Expand the sales of handpieces
and enhance after-sales
service by our local subsidiaryas demand is expected to
decline after the reversal ofstrong trend.

Marketoutlook▪Expand the sales of handpieces
and implant related products
as demand is expected to
decline due to the reversal of
extraordinary demand in FY2021.

23

Dental Business Topics
Global dental trade shows are beginning to reopen
2021/09/09～

2021/10/11～

EXPO DENTAL
2021 (Italy)

ADA 2021 (U.S.)

2021/09/22～

2022/01/27～

International
Dental Show
2021 (Germany)

Yankee Dental
Congress (U.S.)

2021/09/27～

2022/02/01～

Dental Expo
Moscow (Russia)

AEEDC (UAE)© 2022 NAKANISHI INC.

24

Industrial Business Outline

Overview of FY2021
Achieved record-high orders and higher sales in all markets, backed by strong
capital investment in the manufacturing sector.
▪Japan:Sales increased as we won capital investment projects, which were booming during theyear, particularly those related to semiconductors.

▪Europe:Demand improved and inquires increased. Sales grew, particularly for motor spindles.

▪N. America:

Sales grew strongly for application deployment projects for factory automation.

▪Asia:In China, where capital investment projects remained strong, we won a large
number of contracts.

Measures for FY2022
With demand trending upward, orders are expected to remain high. Overall
performance, however, depends on how the situation will develop with regard
to components procurement.
▪Japan:Further explore opportunities in automotive-related industries and continue theenhancement of digital marketing tools.

▪Europe:

Market is expected to be strong, leading to a large number of inquiries. Continue ourcomponents procurement efforts to ensure timely product supply.

▪N. America:

Further expand operations by consolidating our local subsidiary and enhancing thesales agency network.

▪Asia:

Capital investment in 5G and related areas remains strong. Continue
vigorous sales activities.
© 2022 NAKANISHI INC.

25

Industrial Business Topics
Expand sales of the new products launched by the end of FY2021
New motor spindles

New micro grinders

Launched in Aug. 2020

Launched in Aug. 2021

Launched in Jul. 2020

Launched in Jul. 2021

Ultrasonic polisher

Ultrasonic cutter

Electro-static discharge spindle

Coolant through spindle

Sheenus ZERO

Sonic Cutter ZERO

NR33-6000ATC-ESD

CTS - 3030

© 2022 NAKANISHI INC.

26

Medical Business Outline* Medical business is included in Dental segment

Overview of FY2021
The number of surgeries that decreased due to COVID-19 was on a recovery path.
Sales grew as we captured increasing demand.
▪Japan:Sales increased for both the unit body and disposables due to successful sales follow-up
efforts in the period that demand was recovering.

▪Europe:

Sales for disposables were strong, backed by the progress in the deployment of ourdevices in major hospitals in the region.

▪N. America:

Sales for the unit body grew due to successful sales expansion leveraging the channels ofalliance partners.

▪Asia:

Sales for disposables grew, supported by our promotion campaigns targeting large-scale
hospitals.

Measures for FY2022
Launch and expand the sales of our new product “P300AT” in North America,
leveraging an alliance with partners.
▪Japan:Strengthen sales promotion to otorhinolaryngology and other areas, in addition to spinal
surgery, our main target.

▪Europe:

Aim to expand the sale of disposables to existing customers and to deploy our devices tomajor hospitals.

▪N. America:

Aim to expand the sale of our new product “P300AT” and to expand sales channels byleveraging the channels of alliance partners.

▪Asia:

Enhance the sales agency network and aim to increase our addressable market (thenumber of the unit body in operation)© 2022 NAKANISHI INC.

27

Medical Business Topics
Enhance customer contact through product training sessions

Control unit

Slim motor andP300 Attachment

Otorhinolaryngology hands-on course
at MAYO CLINIC HOSPITAL in the U.S.A.

© 2022 NAKANISHI INC.

Electric bone cutting
device that can be usedin neuro, orthopedic
surgeries etc.

QuadEdge bur”Primado2” series products
used in the hands-on course

28

Sustainability for NAKANISHI
We will implement concrete initiatives to address climate change, circular
economy, human rights and other sustainability issues, with the goal of
creating "brilliant progress" via "innovative grinding technology.”❚System of NAKANISHI’s Corporate Philosophy

Sustainability
Report 2021

❚Materiality for Sustainability
Materiality

Relevant SDGs

innovative and safe products
1 Providing
Contribute directly to health, welfare and industrial

infrastructure through the provision of products and services

M issio n

2 Provide product knowledge and best clinicalknowledge

Creating"brilliant progress“via "innovative grinding
technology”

Disseminate and share advanced clinical technologies through
NSK Academy activities, etc.

3 Extend product life through expanded
service structure

V i s i on

Contribute by our reliable and durable quality to our customers

To be The Leading Excellent Global
Medical Device Company

Mid term Biz Plan

CSR

Mid term Management Plan
NV 2025

Materiality forsustainability

4 Develop human resources for advanced
manufacturing

Strengthen human resources as the most important businessfoundation for continuing to provide products and services

5 Promote occupational safety and health &health and productivity management
Pursue workplaces for the creation of innovative products

6 Create workplaces where diverse humanresources can grow
Implement diversity and inclusion

S ty l e

7 Respect our business partners around theworld

E xc itin g / Q ua lity / O pen / H on est

Implement sincere and fair corporate activities

Annual President’s Policy

Department Action Plans

Daily Business Activities

8 Response to climate change andcontribution to a recycling-oriented society

Contribute to reducing environmental impact through products,
services and business processes© 2022 NAKANISHI INC.

29

Concrete Sustainability Initiatives

Dual Defense™

Relevant
SDGs

Our original infection
prevention systems

Ecologicalpackaging

For more than 30 years, we havebeen developing products that help
both dentists and patients to engage
in dental treatment with a sense of
security, including our original
infection prevention system, whichis the first of its kind.

We have changed package
material from plastics to recycled
paper and reduced the size andweight of packages, as part of ourefforts to reduce plastic waste andmitigate the environmental impactof logistics.

Our materiality for sustainability
1. Proving innovative andsafe products

Relevant
SDGs

8. Response to climate change
and contribution to a recyclingoriented society

Product training
sessions

Zero CO2
manufacturing

We provide product training
sessions to help users to deepen
their understanding of our
products and make the full useof their functions.

We have changed all the electricity
used at our head office and plant A1
to renewable energy (solar power
and wind power). We will continue totake climate action while sustaining
our business activities.

This initiative has contributed to
improving customer satisfaction
and advancing dental treatment
technology.

Relevant
SDGs

Our materiality for sustainability

Our materiality for sustainability
2. Provide product knowledge
and best clinical knowledge

Relevant
SDGs© 2022 NAKANISHI INC.

Our materiality for sustainability
8. Response to climate change
and contribution to a recyclingoriented society

30